 | • レポートコード：QYR9ST04714 • 出版社/出版日：QYResearch / 2019年9月2日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、98ページ • 納品方法：Eメール（受注後2-3営業日） • 産業分類：医療・製薬 |
| Single User | ￥577,200 (USD3,900) | ▷ お問い合わせ |
| Enterprise License | ￥1,154,400 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| ※当調査レポートでは、良性前立腺過形成検査の世界市場について調査・分析し、良性前立腺過形成検査の世界市場規模、市場動向、主要企業別マーケットシェア、主要地域別市場規模、企業プロフィールなどの情報をまとめました。また、セグメント分析では、種類別（尿検査、前立腺特異抗原（PSA）血液検査、尿力学検査、膀胱鏡検査）、用途別（病院、診断センター、診療所、研究機関）、地域別（北米、ヨーロッパ、中国、日本国内、東南アジア、インド、中南米）に区分して市場規模を算出しました。 ・レポートの概要 ・世界の良性前立腺過形成検査市場動向 ・主要企業別マーケットシェア ・良性前立腺過形成検査の種類別市場規模2014-2019 （尿検査、前立腺特異抗原（PSA）血液検査、尿力学検査、膀胱鏡検査） ・良性前立腺過形成検査の用途別市場規模2014-2019 （病院、診断センター、診療所、研究機関） ・良性前立腺過形成検査の北米市場：主要企業・種類別/用途別市場規模 ・良性前立腺過形成検査のヨーロッパ市場：主要企業・種類別/用途別市場規模 ・良性前立腺過形成検査の中国市場：主要企業・種類別/用途別市場規模 ・良性前立腺過形成検査の日本国内市場：主要企業・種類別/用途別市場規模 ・良性前立腺過形成検査の東南アジア市場：主要企業・種類別/用途別市場規模 ・良性前立腺過形成検査のインド市場：主要企業・種類別/用途別市場規模 ・良性前立腺過形成検査の中南米市場：主要企業・種類別/用途別市場規模 ・主要企業のプロフィール （AEternaZentaris、Astellas Pharma、Eli Lilly and Company、IntelGenx Technologies Corp、Nymox Pharmaceutical Corporation、Protox Therapeutics、Quest PharmaTech） ・良性前立腺過形成検査の市場規模予測2019-2025 （種類別、用途別、地域別市場予測） ・アナリストの観点・結論 ... |
Benign prostatic hyperplasia (BPH) is a condition occurring in men when the prostate gland is enlarged. Benign prostatic hyperplasia is also termed as benign prostatic hypertrophy or benign prostatic obstruction. Prostate gland grows in primarily two phases, firstly during puberty when the size of the prostate doubles and the second growth phase starts at 25 years and continues throughout the lifetime. While the prostate gland enlarges in a man, it presses and pinches the urethra making the bladder wall thick. This pressure and squeeze on the urethra weaken the bladder and makes it lose the ability to empty the urine completely. Urinary retention and narrowing of the urethra can cause many problems which are associated with benign prostatic hyperplasia. Benign prostatic hyperplasia is one of the common prostate problems for men older than age 50.Benign prostatic hyperplasia testing market is primarily driven by a few key factors such as the growing geriatric male population, patient awareness regarding rising healthcare concerns, increase in healthcare expenditure, increasing government initiatives and availability of minimally invasive surgery as a drug replacement, faster and easy performing diagnosis test results. The market is likely to grow owing to the novel diagnostic methods which are accurate than the conventional PSA blood test for benign prostatic hyperplasia which is effective in diagnosis and is expected to fuel the growth of benign prostatic hyperplasia testing market.
However, faces various challenges such as researchers which have found new ways to prevent the disease. Benign prostatic hyperplasia testing market tests are still in the primary stages of development which is a major restraint for the market. Benign Prostatic Hyperplasia Testing Market faces tremendous challenges due to the low awareness regarding the various diseases and diagnostic measures. Low-income countries and rising economies are coming forward to address such issues for benign prostatic hyperplasia testing market.
In 2018, the global Benign Prostatic Hyperplasia Testing market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.
This report focuses on the global Benign Prostatic Hyperplasia Testing status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Benign Prostatic Hyperplasia Testing development in United States, Europe and China.
The key players covered in this study
AEternaZentaris
Astellas Pharma
Eli Lilly and Company
IntelGenx Technologies Corp
Nymox Pharmaceutical Corporation
Protox Therapeutics
Quest PharmaTech
…
Market segment by Type, the product can be split into
Urinalysis
Prostate-Specific Antigen (PSA) Blood Test
Urodynamic Test
Cystoscopy
Market segment by Application, split into
Hospitals
Diagnostic Centers
Clinics
Research Institutes
Market segment by Regions/Countries, this report covers
United States
Europe
China
Japan
Southeast Asia
India
Central & South America
The study objectives of this report are:
To analyze global Benign Prostatic Hyperplasia Testing status, future forecast, growth opportunity, key market and key players.
To present the Benign Prostatic Hyperplasia Testing development in United States, Europe and China.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.
In this study, the years considered to estimate the market size of Benign Prostatic Hyperplasia Testing are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Table of Contents
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered
1.4 Market Analysis by Type
1.4.1 Global Benign Prostatic Hyperplasia Testing Market Size Growth Rate by Type (2014-2025)
1.4.2 Urinalysis
1.4.3 Prostate-Specific Antigen (PSA) Blood Test
1.4.4 Urodynamic Test
1.4.5 Cystoscopy
1.5 Market by Application
1.5.1 Global Benign Prostatic Hyperplasia Testing Market Share by Application (2014-2025)
1.5.2 Hospitals
1.5.3 Diagnostic Centers
1.5.4 Clinics
1.5.5 Research Institutes
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends
2.1 Benign Prostatic Hyperplasia Testing Market Size
2.2 Benign Prostatic Hyperplasia Testing Growth Trends by Regions
2.2.1 Benign Prostatic Hyperplasia Testing Market Size by Regions (2014-2025)
2.2.2 Benign Prostatic Hyperplasia Testing Market Share by Regions (2014-2019)
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Opportunities
3 Market Share by Key Players
3.1 Benign Prostatic Hyperplasia Testing Market Size by Manufacturers
3.1.1 Global Benign Prostatic Hyperplasia Testing Revenue by Manufacturers (2014-2019)
3.1.2 Global Benign Prostatic Hyperplasia Testing Revenue Market Share by Manufacturers (2014-2019)
3.1.3 Global Benign Prostatic Hyperplasia Testing Market Concentration Ratio (CR5 and HHI)
3.2 Benign Prostatic Hyperplasia Testing Key Players Head office and Area Served
3.3 Key Players Benign Prostatic Hyperplasia Testing Product/Solution/Service
3.4 Date of Enter into Benign Prostatic Hyperplasia Testing Market
3.5 Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Type and Application
4.1 Global Benign Prostatic Hyperplasia Testing Market Size by Type (2014-2019)
4.2 Global Benign Prostatic Hyperplasia Testing Market Size by Application (2014-2019)
5 United States
5.1 United States Benign Prostatic Hyperplasia Testing Market Size (2014-2019)
5.2 Benign Prostatic Hyperplasia Testing Key Players in United States
5.3 United States Benign Prostatic Hyperplasia Testing Market Size by Type
5.4 United States Benign Prostatic Hyperplasia Testing Market Size by Application
6 Europe
6.1 Europe Benign Prostatic Hyperplasia Testing Market Size (2014-2019)
6.2 Benign Prostatic Hyperplasia Testing Key Players in Europe
6.3 Europe Benign Prostatic Hyperplasia Testing Market Size by Type
6.4 Europe Benign Prostatic Hyperplasia Testing Market Size by Application
7 China
7.1 China Benign Prostatic Hyperplasia Testing Market Size (2014-2019)
7.2 Benign Prostatic Hyperplasia Testing Key Players in China
7.3 China Benign Prostatic Hyperplasia Testing Market Size by Type
7.4 China Benign Prostatic Hyperplasia Testing Market Size by Application
8 Japan
8.1 Japan Benign Prostatic Hyperplasia Testing Market Size (2014-2019)
8.2 Benign Prostatic Hyperplasia Testing Key Players in Japan
8.3 Japan Benign Prostatic Hyperplasia Testing Market Size by Type
8.4 Japan Benign Prostatic Hyperplasia Testing Market Size by Application
9 Southeast Asia
9.1 Southeast Asia Benign Prostatic Hyperplasia Testing Market Size (2014-2019)
9.2 Benign Prostatic Hyperplasia Testing Key Players in Southeast Asia
9.3 Southeast Asia Benign Prostatic Hyperplasia Testing Market Size by Type
9.4 Southeast Asia Benign Prostatic Hyperplasia Testing Market Size by Application
10 India
10.1 India Benign Prostatic Hyperplasia Testing Market Size (2014-2019)
10.2 Benign Prostatic Hyperplasia Testing Key Players in India
10.3 India Benign Prostatic Hyperplasia Testing Market Size by Type
10.4 India Benign Prostatic Hyperplasia Testing Market Size by Application
11 Central & South America
11.1 Central & South America Benign Prostatic Hyperplasia Testing Market Size (2014-2019)
11.2 Benign Prostatic Hyperplasia Testing Key Players in Central & South America
11.3 Central & South America Benign Prostatic Hyperplasia Testing Market Size by Type
11.4 Central & South America Benign Prostatic Hyperplasia Testing Market Size by Application
12 International Players Profiles
12.1 AEternaZentaris
12.1.1 AEternaZentaris Company Details
12.1.2 Company Description and Business Overview
12.1.3 Benign Prostatic Hyperplasia Testing Introduction
12.1.4 AEternaZentaris Revenue in Benign Prostatic Hyperplasia Testing Business (2014-2019)
12.1.5 AEternaZentaris Recent Development
12.2 Astellas Pharma
12.2.1 Astellas Pharma Company Details
12.2.2 Company Description and Business Overview
12.2.3 Benign Prostatic Hyperplasia Testing Introduction
12.2.4 Astellas Pharma Revenue in Benign Prostatic Hyperplasia Testing Business (2014-2019)
12.2.5 Astellas Pharma Recent Development
12.3 Eli Lilly and Company
12.3.1 Eli Lilly and Company Company Details
12.3.2 Company Description and Business Overview
12.3.3 Benign Prostatic Hyperplasia Testing Introduction
12.3.4 Eli Lilly and Company Revenue in Benign Prostatic Hyperplasia Testing Business (2014-2019)
12.3.5 Eli Lilly and Company Recent Development
12.4 IntelGenx Technologies Corp
12.4.1 IntelGenx Technologies Corp Company Details
12.4.2 Company Description and Business Overview
12.4.3 Benign Prostatic Hyperplasia Testing Introduction
12.4.4 IntelGenx Technologies Corp Revenue in Benign Prostatic Hyperplasia Testing Business (2014-2019)
12.4.5 IntelGenx Technologies Corp Recent Development
12.5 Nymox Pharmaceutical Corporation
12.5.1 Nymox Pharmaceutical Corporation Company Details
12.5.2 Company Description and Business Overview
12.5.3 Benign Prostatic Hyperplasia Testing Introduction
12.5.4 Nymox Pharmaceutical Corporation Revenue in Benign Prostatic Hyperplasia Testing Business (2014-2019)
12.5.5 Nymox Pharmaceutical Corporation Recent Development
12.6 Protox Therapeutics
12.6.1 Protox Therapeutics Company Details
12.6.2 Company Description and Business Overview
12.6.3 Benign Prostatic Hyperplasia Testing Introduction
12.6.4 Protox Therapeutics Revenue in Benign Prostatic Hyperplasia Testing Business (2014-2019)
12.6.5 Protox Therapeutics Recent Development
12.7 Quest PharmaTech
12.7.1 Quest PharmaTech Company Details
12.7.2 Company Description and Business Overview
12.7.3 Benign Prostatic Hyperplasia Testing Introduction
12.7.4 Quest PharmaTech Revenue in Benign Prostatic Hyperplasia Testing Business (2014-2019)
12.7.5 Quest PharmaTech Recent Development
13 Market Forecast 2019-2025
13.1 Market Size Forecast by Regions
13.2 United States
13.3 Europe
13.4 China
13.5 Japan
13.6 Southeast Asia
13.7 India
13.8 Central & South America
13.9 Market Size Forecast by Product (2019-2025)
13.10 Market Size Forecast by Application (2019-2025)
14 Analyst’s Viewpoints/Conclusions
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
12.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Disclaimer
15.3 Author Details
Table Benign Prostatic Hyperplasia Testing Key Market Segments
Table Key Players Benign Prostatic Hyperplasia Testing Covered
Table Global Benign Prostatic Hyperplasia Testing Market Size Growth Rate by Type 2014-2025 (Million US$)
Figure Global Benign Prostatic Hyperplasia Testing Market Size Market Share by Type 2014-2025
Figure Urinalysis Figures
Table Key Players of Urinalysis
Figure Prostate-Specific Antigen (PSA) Blood Test Figures
Table Key Players of Prostate-Specific Antigen (PSA) Blood Test
Figure Urodynamic Test Figures
Table Key Players of Urodynamic Test
Figure Cystoscopy Figures
Table Key Players of Cystoscopy
Table Global Benign Prostatic Hyperplasia Testing Market Size Growth by Application 2014-2025 (Million US$)
Figure Hospitals Case Studies
Figure Diagnostic Centers Case Studies
Figure Clinics Case Studies
Figure Research Institutes Case Studies
Figure Benign Prostatic Hyperplasia Testing Report Years Considered
Table Global Benign Prostatic Hyperplasia Testing Market Size 2014-2025 (Million US$)
Figure Global Benign Prostatic Hyperplasia Testing Market Size and Growth Rate 2014-2025 (Million US$)
Table Global Benign Prostatic Hyperplasia Testing Market Size by Regions 2014-2025 (Million US$)
Table Global Benign Prostatic Hyperplasia Testing Market Size by Regions 2014-2019 (Million US$)
Table Global Benign Prostatic Hyperplasia Testing Market Share by Regions 2014-2019
Figure Global Benign Prostatic Hyperplasia Testing Market Share by Regions 2014-2019
Figure Global Benign Prostatic Hyperplasia Testing Market Share by Regions 2019
Table Market Top Trends
Table Global Benign Prostatic Hyperplasia Testing Revenue by Manufacturers (2014-2019) (Million US$)
Table Global Benign Prostatic Hyperplasia Testing Market Share by Manufacturers (2014-2019)
Figure Global Benign Prostatic Hyperplasia Testing Market Share by Manufacturers in 2018
Table Global Benign Prostatic Hyperplasia Testing Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Key Players Head office and Area Served
Table Key Players Benign Prostatic Hyperplasia Testing Product/Solution/Service
Table Date of Enter into Benign Prostatic Hyperplasia Testing Market
Table Mergers & Acquisitions, Expansion Plans
Table Global Benign Prostatic Hyperplasia Testing Market Size by Type (2014-2019) (Million US$)
Table Global Benign Prostatic Hyperplasia Testing Market Size Share by Type (2014-2019)
Figure Global Benign Prostatic Hyperplasia Testing Market Size Market Share by Type (2014-2019)
Table Global Benign Prostatic Hyperplasia Testing Market Size by Application (2014-2019) (Million US$)
Table Global Benign Prostatic Hyperplasia Testing Market Size Share by Application (2014-2019)
Figure Global Benign Prostatic Hyperplasia Testing Market Size Market Share by Application (2014-2019)
Figure Global Benign Prostatic Hyperplasia Testing Revenue Market Share by Application in 2018
Figure United States Benign Prostatic Hyperplasia Testing Market Size 2014-2019 (Million US$)
Table United States Key Players Benign Prostatic Hyperplasia Testing Revenue (2018-2019) (Million US$)
Table United States Key Players Benign Prostatic Hyperplasia Testing Market Share (2018-2019)
Table United States Benign Prostatic Hyperplasia Testing Market Size by Type (2014-2019) (Million US$)
Table United States Benign Prostatic Hyperplasia Testing Market Share by Type (2014-2019)
Table United States Benign Prostatic Hyperplasia Testing Market Size by Application (2014-2019) (Million US$)
Table United States Benign Prostatic Hyperplasia Testing Market Share by Application (2014-2019)
Figure Europe Benign Prostatic Hyperplasia Testing Market Size 2014-2019 (Million US$)
Table Europe Key Players Benign Prostatic Hyperplasia Testing Revenue (2018-2019) (Million US$)
Table Europe Key Players Benign Prostatic Hyperplasia Testing Market Share (2018-2019)
Table Europe Benign Prostatic Hyperplasia Testing Market Size by Type (2014-2019) (Million US$)
Table Europe Benign Prostatic Hyperplasia Testing Market Share by Type (2014-2019)
Table Europe Benign Prostatic Hyperplasia Testing Market Size by Application (2014-2019) (Million US$)
Table Europe Benign Prostatic Hyperplasia Testing Market Share by Application (2014-2019)
Figure China Benign Prostatic Hyperplasia Testing Market Size 2014-2019 (Million US$)
Table China Key Players Benign Prostatic Hyperplasia Testing Revenue (2018-2019) (Million US$)
Table China Key Players Benign Prostatic Hyperplasia Testing Market Share (2018-2019)
Table China Benign Prostatic Hyperplasia Testing Market Size by Type (2014-20189) (Million US$)
Table China Benign Prostatic Hyperplasia Testing Market Share by Type (2014-2019)
Table China Benign Prostatic Hyperplasia Testing Market Size by Application (2014-2019) (Million US$)
Table China Benign Prostatic Hyperplasia Testing Market Share by Application (2014-2019)
Figure Japan Benign Prostatic Hyperplasia Testing Market Size 2014-2019 (Million US$)
Table Japan Key Players Benign Prostatic Hyperplasia Testing Revenue (2018-2019) (Million US$)
Table Japan Key Players Benign Prostatic Hyperplasia Testing Market Share (2018-2019)
Table Japan Benign Prostatic Hyperplasia Testing Market Size by Type (2014-2019) (Million US$)
Table Japan Benign Prostatic Hyperplasia Testing Market Share by Type (2014-2019)
Table Japan Benign Prostatic Hyperplasia Testing Market Size by Application (2014-2019) (Million US$)
Table Japan Benign Prostatic Hyperplasia Testing Market Share by Application (2014-2019)
Figure Southeast Asia Benign Prostatic Hyperplasia Testing Market Size 2014-2019 (Million US$)
Table Southeast Asia Key Players Benign Prostatic Hyperplasia Testing Revenue (2018-2019) (Million US$)
Table Southeast Asia Key Players Benign Prostatic Hyperplasia Testing Market Share (2018-2019)
Table Southeast Asia Benign Prostatic Hyperplasia Testing Market Size by Type (2014-2019) (Million US$)
Table Southeast Asia Benign Prostatic Hyperplasia Testing Market Share by Type (2014-2019)
Table Southeast Asia Benign Prostatic Hyperplasia Testing Market Size by Application (2014-2019) (Million US$)
Table Southeast Asia Benign Prostatic Hyperplasia Testing Market Share by Application (2014-2019)
Figure India Benign Prostatic Hyperplasia Testing Market Size 2014-2019 (Million US$)
Table India Key Players Benign Prostatic Hyperplasia Testing Revenue (2018-2019) (Million US$)
Table India Key Players Benign Prostatic Hyperplasia Testing Market Share (2018-2019)
Table India Benign Prostatic Hyperplasia Testing Market Size by Type (2014-2019) (Million US$)
Table India Benign Prostatic Hyperplasia Testing Market Share by Type (2014-2019)
Table India Benign Prostatic Hyperplasia Testing Market Size by Application (2014-2019) (Million US$)
Table India Benign Prostatic Hyperplasia Testing Market Share by Application (2014-2019)
Figure Central & South America Benign Prostatic Hyperplasia Testing Market Size 2014-2019 (Million US$)
Table Central & South America Key Players Benign Prostatic Hyperplasia Testing Revenue (2018-2019) (Million US$)
Table Central & South America Key Players Benign Prostatic Hyperplasia Testing Market Share (2018-2019)
Table Central & South America Benign Prostatic Hyperplasia Testing Market Size by Type (2014-2019) (Million US$)
Table Central & South America Benign Prostatic Hyperplasia Testing Market Share by Type (2014-2019)
Table Central & South America Benign Prostatic Hyperplasia Testing Market Size by Application (2014-2019) (Million US$)
Table Central & South America Benign Prostatic Hyperplasia Testing Market Share by Application (2014-2019)
Table AEternaZentaris Company Details
Table AEternaZentaris Revenue in Benign Prostatic Hyperplasia Testing Business (2014-2019) (Million US$)
Figure AEternaZentaris Revenue Growth Rate in Benign Prostatic Hyperplasia Testing Business (2014-2019)
Table AEternaZentaris Recent Development
Table Astellas Pharma Company Details
Table Astellas Pharma Revenue in Benign Prostatic Hyperplasia Testing Business (2014-2019)(Million US$)
Figure Astellas Pharma Revenue Growth Rate in Benign Prostatic Hyperplasia Testing Business (2014-2019)
Table Astellas Pharma Recent Development
Table Eli Lilly and Company Company Details
Table Eli Lilly and Company Revenue in Benign Prostatic Hyperplasia Testing Business (2014-2019)(Million US$)
Figure Eli Lilly and Company Revenue Growth Rate in Benign Prostatic Hyperplasia Testing Business (2014-2019)
Table Eli Lilly and Company Recent Development
Table IntelGenx Technologies Corp Company Details
Table IntelGenx Technologies Corp Revenue in Benign Prostatic Hyperplasia Testing Business (2014-2019)(Million US$)
Figure IntelGenx Technologies Corp Revenue Growth Rate in Benign Prostatic Hyperplasia Testing Business (2014-2019)
Table IntelGenx Technologies Corp Recent Development
Table Nymox Pharmaceutical Corporation Company Details
Table Nymox Pharmaceutical Corporation Revenue in Benign Prostatic Hyperplasia Testing Business (2014-2019)(Million US$)
Figure Nymox Pharmaceutical Corporation Revenue Growth Rate in Benign Prostatic Hyperplasia Testing Business (2014-2019)
Table Nymox Pharmaceutical Corporation Recent Development
Table Protox Therapeutics Company Details
Table Protox Therapeutics Revenue in Benign Prostatic Hyperplasia Testing Business (2014-2019)(Million US$)
Figure Protox Therapeutics Revenue Growth Rate in Benign Prostatic Hyperplasia Testing Business (2014-2019)
Table Protox Therapeutics Recent Development
Table Quest PharmaTech Company Details
Table Quest PharmaTech Revenue in Benign Prostatic Hyperplasia Testing Business (2014-2019)(Million US$)
Figure Quest PharmaTech Revenue Growth Rate in Benign Prostatic Hyperplasia Testing Business (2014-2019)
Table Quest PharmaTech Recent Development
Table Global Benign Prostatic Hyperplasia Testing Market Size by Regions (Million US$) 2019-2025
Figure Global Benign Prostatic Hyperplasia Testing Market Size Share by Regions (2019-2025)
Figure Global Benign Prostatic Hyperplasia Testing Market Size Share by Regions in 2025
Figure United States Benign Prostatic Hyperplasia Testing Market Size Forecast (2019-2025)(Million USD)
Figure Europe Benign Prostatic Hyperplasia Testing Market Size Forecast (2019-2025)(Million USD)
Figure China Benign Prostatic Hyperplasia Testing Market Size Forecast (2019-2025)(Million USD)
Figure Japan Benign Prostatic Hyperplasia Testing Market Size Forecast (2019-2025)(Million USD)
Figure Southeast Asia Benign Prostatic Hyperplasia Testing Market Size Forecast (2019-2025)(Million USD)
Figure India Benign Prostatic Hyperplasia Testing Market Size Forecast (2019-2025)(Million USD)
Figure Central & South America Benign Prostatic Hyperplasia Testing Market Size Forecast (2019-2025)(Million USD)
Table Global Benign Prostatic Hyperplasia Testing Market Size by Product (2019-2025) (Million US$)
Figure Global Benign Prostatic Hyperplasia Testing Market Size by Product (2019-2025)
Figure Global Benign Prostatic Hyperplasia Testing Market Size by Product in 2025
Table Global Benign Prostatic Hyperplasia Testing Market Size by Application (2019-2025) (Million US$)
Figure Global Benign Prostatic Hyperplasia Testing Market Size by Application (2019-2025)
Figure Global Benign Prostatic Hyperplasia Testing Market Size by Application in 2025
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources
良性前立腺過形成（BPH）薬の世界市場：インサイト・予測 Urology is a branch of medicine that deals with the health of the urinary tract and reproductive tract in men and women. Urologic diseases or conditions include infection in the urinary tract, bladder control problems, kidney stones and prostate problems, among others. The prostate gland surrounds t…- 血液ウイルス検査の世界市場：市場規模・現状・予測 Viral testing is carried out to detect infections caused by viruses by destroying cells of immune system. Viruses breed only in living cells and cause diseases by destructing or injuring the cells they infect, damaging the body's whole immune system, altering the genetic material (DNA) of the cells …
- 免疫タンパク質診断検査の世界市場：市場規模・現状・予測 Immunoprotein is an immunologically active protein, which provides immunity against pathogenic organisms or substances. These proteins form the integrated body system of tissues, organs, cells, or cell products that neutralize antigens. They enable the diagnosis of various diseases, such as cardiova…
- 世界の良性再発性肝内胆汁うっ滞（BRIC）画像診断装置市場：専門的調査 BRIC diagnostic imaging equipment market is broadly segmented into six segments—X-ray imaging systems, CT scanners, ultrasound imaging systems, MRI systems, nuclear imaging systems, and mammography systems. The global Benign Recurrent Intrahepatic Cholestasis (BRIC) Diagnostic Imaging Equipment mar…
- 血液検査の世界市場：市場規模・現状・予測 A blood test is the analysis of blood sample performed in a laboratory and the blood is usually taken from the vein in the arm through a needle, or through a finger prick to determine patient’s health status. Blood tests are very often used in health care to understand biochemical and physiological …